Journal article
CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain.
- Abstract:
-
The cannabinoid agonist, HU210 has been evaluated in vivo in nociceptive and inflammatory pain models in the rat. The ED50 for the anti-nociceptive (increasing mechanical withdrawal threshold) effect was 0.1 mg/kg-1 i.p., and for anti-hypersensitivity and anti-inflammatory activity was 5 g/kg-1 i.p. (in the carrageenan model). The selective CB1 antagonist, AM281 (0.5 microg/kg-1 i.p.) reversed effects of HU210 (10 and 30 microg/kg-1 i.p.) in both nociceptive and inflammatory models of hyperse...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Pain
- Volume:
- 96
- Issue:
- 3
- Pages:
- 253-260
- Publication date:
- 2002-04-01
- DOI:
- EISSN:
-
1872-6623
- ISSN:
-
0304-3959
- Source identifiers:
-
32095
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:32095
- UUID:
-
uuid:4d0a190e-beb9-4796-a4b9-6211dd4616c5
- Local pid:
- pubs:32095
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2002
If you are the owner of this record, you can report an update to it here: Report update to this record